Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair



Rating:

Share or cite this content

Citations should be made in the following way:
C. Rowan Simon, X. Liu (xue.liu@cshs.org / Cedars-Sinai Medical Centre,Los Angeles), Y. Wang (yizhou.wang@cshs.org / Cedars-Sinai Medical Centre,Los Angeles), P. W. Noble (paul.noble@cshs.org / Cedars-Sinai Medical Centre,Los Angeles), D. Jiang (dianhua.jiang@cshs.org / Cedars-Sinai Medical Centre,Los Angeles). LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung.. 2693

Member's Comments

No comment yet.

Related content which might interest you: YI401 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 Preclinical studies of mesenchymal stem cell (MSC) transplantation in chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 LSC - 2018 - Material properties of lung scaffolds derived from healthy and IPF donor tissues are associated with disease pathology Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Epithelial mesenchymal transition (EMT) in the small and large airways of lung cancer patients undergoing thoracotomy Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 LSC - 2021 - Associations between pediatric asthma and adult lung diseases Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 YI04 - Recruitment of stem cell populations to the lung with disease Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015